About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
56 y/o Female with a History of Hepatitis C, Cirrhosis, Exertional Dyspnea and PAH: Clinical Examination and Treatment Considerations
By
Scripps Health
FEATURING
Rajeev Mohan
,
Ajay Srivastava
,
Thomas Heywood
March 5, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
01:13
Novo Nordisk – GLP-1 RA Therapy
ADA Guidelines for T2D: What Is the Preferred Next Step After Oral A…
Feat.
C. Wierum,
L. Coco
Featured Video
11:40
Novo Nordisk – GLP-1 RA Therapy
GLP-1 RA as a First Injectable for T2D: Is It as Effective as Basal …
Feat.
C. Wierum,
L. Coco
Related Content
AUTOPLAY
ON
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
Feat.
S. Inzucchi
11:37
ACC 2022 Conference Coverage
ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…
Feat.
P. Heidenreich
11:25
ACC 2023 Conference Coverage
ACC 2023: SGLT2i Use - Dos and Don'ts
Feat.
A. Armbruster
18:43
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century …
Feat.
R. DeFronzo
26:01
Cardiology Fiesta 2017
Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…
Feat.
R. DeFronzo
19:40
Sonja Bartolome
PAH Treatment Algorithm
17:44
Rita Jermyn
SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease
27:24
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
Feat.
L. Sloan
14:02
Georgia Heart Institute
Heart Failure Therapies
Feat.
U. Egolum,
H. Samady
21:07
Gilead
Combination Therapy in Pulmonary Arterial Hypertension
Feat.
M. Chakinala, MD,
I. Preston, MD
19:30
ACC 2022 Conference Coverage
Hot Topics in Heart Failure ACC.22
Feat.
N. Ibrahim
22:00
CHEST 2023 Insights
CHEST 2023 Insights: Pulmonary Hypertension Treatment - How to Start…
Feat.
J. Elwing
14:12
Cardiometabolic Health Congress (CMHC)
Drawing the Line Between Primary and Secondary Cardiovascular Preven…
Feat.
S. Virani,
P. Taub
22:48
Scripps Health
Heart Failure with Preserved Ejection Fraction: New Treatments
Feat.
R. C. Mohan
18:05
The Texas Heart Institute
Inside the Studio w/ Dr. Stephanie Coulter | Dr. Darren McGuire
Feat.
S. Coulter,
D. K. Mcguire
35:15
Scripps Health: Fourth Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension
Pulmonary Arterial Hypertension: Who, When and How to Treat?
Feat.
R. Mohan
25:32
The Texas Heart Institute
Heart Failure Guidelines
Feat.
B. Bozkurt
13:42
George Bakris
Current Status of Prevention and Treatment of Diabetic Nephropathy
10:02
Emory Diabetes Education Training Academy
Insulin Treatment in Patients with Type 2 Diabetes: When to Use Comb…
Feat.
G. Umpierrez
04:33
Houston Methodist DeBakey Heart and Vascular Center
Novel Treatment Targets in Pulmonary Arterial Hypertension
Feat.
A. Tonelli
